Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
03/05/2015 | WO2015030149A1 Biomolecular group related to cell anti-aging |
03/05/2015 | WO2015030106A1 Compound having ggt inhibitory effect, and ggt-family enzyme inhibitor |
03/05/2015 | WO2015030078A1 Therapeutic agent for ectocornea injury |
03/05/2015 | WO2015030057A1 Novel morpholine derivative or salt thereof |
03/05/2015 | WO2015030021A1 Pharmaceutical composition having pyrimidine compound as active ingredient |
03/05/2015 | WO2015029968A1 Clock gene expression level modifier |
03/05/2015 | WO2015029923A1 Ophthalmological preparation |
03/05/2015 | WO2015029134A1 Ginsenoside composition |
03/05/2015 | WO2015027820A1 Use of human nectin-2 protein |
03/04/2015 | EP2843049A1 Neuronal differentiation promoter |
03/04/2015 | EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF |
03/04/2015 | EP2842966A1 Therapeutic agent for injury in epithelium and endothelium |
03/04/2015 | EP2842955A1 Trk-INHIBITING COMPOUND |
03/04/2015 | EP2842946A1 Quinazolinedione derivative |
03/04/2015 | EP2842945A1 Sulfonamide derivative and medicinal use thereof |
03/04/2015 | EP2842939A1 Benzamide derivative |
03/04/2015 | EP2842574A1 Sustained release carrier for drugs |
03/04/2015 | EP2842561A1 Enteral environment-improving agent |
03/04/2015 | EP2842560A1 Composition for promoting bifidobacteria growth |
03/04/2015 | EP2842558A1 Cgrp responsiveness promoter |
03/04/2015 | EP2841939A1 Method for detoxification or measurement of at least one compound or at least one fluid in a host body |
03/04/2015 | EP2841579A1 Microrna compounds and methods for modulating mir-21 activity |
03/04/2015 | EP2841435A1 Pyrrolopyridinone derivatives as ttx-s blockers |
03/04/2015 | EP2841421A1 Amide derivatives as ttx-s blockers |
03/03/2015 | US8968763 Block biodegradable copolymers for medical devices |
02/26/2015 | WO2015025936A1 Novel quinoline-substituted compound |
02/26/2015 | WO2015025914A1 Salt of indole derivatives and crystal thereof |
02/26/2015 | WO2015025871A1 Methods for evaluating and screening s1p1 receptor agonists |
02/26/2015 | WO2015025816A1 Chymase inhibitor and medicine comprising chymase inhibitor |
02/26/2015 | WO2015025815A1 Polyrotaxane and medicinal composition |
02/25/2015 | EP2840083A1 Nitrogenated bicyclic aromatic heterocyclic compound |
02/25/2015 | EP2840080A1 Nitrogen-containing heterocyclic compound or salt thereof |
02/25/2015 | EP2840076A1 Bicyclic compound |
02/25/2015 | EP2838553A1 Growth enhancement of infants |
02/25/2015 | EP2838541A1 Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies |
02/25/2015 | EP2838528A1 Methods for inhibition of shc-1/p66 to combat aging-related diseases |
02/24/2015 | CA2771403C Quinoline derivative-containing pharmaceutical composition |
02/24/2015 | CA2683534C Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
02/19/2015 | WO2015022962A1 Lipid metabolism accelerator |
02/19/2015 | WO2015022927A1 Amp-activated protein kinase activator |
02/19/2015 | WO2015022926A1 Novel fused pyrimidine compound or salt thereof |
02/18/2015 | EP2837627A1 Amidopyridine derivative, and use thereof |
02/18/2015 | EP2837623A1 Novel 1-substituted indazole derivative |
02/18/2015 | EP2836595A2 Compositions and methods for inhibiting expression of the alas1 gene |
02/17/2015 | CA2759163C Method for producing olmesartan medoxomil |
02/17/2015 | CA2726579C Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
02/17/2015 | CA2679971C Glucokinase activator |
02/17/2015 | CA2669524C Collagen peptide composition and food or beverage containing the same |
02/17/2015 | CA2592532C Sesamin/episesamin compositions with improved bioavailability |
02/17/2015 | CA2563103C Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer |
02/12/2015 | WO2015020194A1 Antisense oligonucleotide against acsl1 |
02/12/2015 | WO2015020184A1 Aromatic compound |
02/12/2015 | WO2015020162A1 Aquaporin 3 expression enhancer and tissue repair accelerator |
02/12/2015 | WO2015020138A1 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same |
02/12/2015 | WO2015020122A1 Urothelial cancer diagnosis and therapeutic agent |
02/12/2015 | WO2015020040A1 Medicine for preventing or suppressing survival of cancer cells and having organic acid polymer as active ingredient |
02/12/2015 | US20150047064 INHIBITING GENE EXPRESSION WITH dsRNA |
02/12/2015 | US20150045552 5ht2c receptor modulators |
02/12/2015 | US20150045536 Universal carrier for targeting molecules to gb3 receptor expressing cells |
02/12/2015 | US20150045375 Novel compounds |
02/12/2015 | US20150044230 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
02/12/2015 | US20150044229 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
02/11/2015 | EP2833877A1 Novel targeting agents for diagnostic and therapeutic indications |
02/11/2015 | EP2762489A9 Glycosylated polypeptide and pharmaceutical composition containing same |
02/11/2015 | EP2412797A9 Process for producing lactic acid bacterium having enhanced immunomodulating activity |
02/11/2015 | CN104350040A 芳环化合物 Aromatic compounds |
02/11/2015 | CN104349786A 骨骼肌慢肌化剂 Slow-twitch skeletal muscle agent |
02/11/2015 | CN104338066A 一种可通经理气的药酒 A gas can pass the wine manager |
02/11/2015 | CN104337877A 一种清热降温药液的生产方法 One kind of heat and cooling liquid production methods |
02/11/2015 | CN104337796A 一种高分子水凝胶儿童退热贴及其制备方法 A polymer hydrogel children cooling paste and preparation method |
02/11/2015 | CN104336390A 一种生鱼的成鱼饲料及其应用 One kind of raw fish into fish feed and its application |
02/11/2015 | CN103417744B 一种治疗小儿疝气的药物及其制备方法 And preparation of a drug for the treatment of infantile colic |
02/11/2015 | CN103417708B 一种治疗疝气的中药丸剂 A treatment for hernia herbal pills |
02/11/2015 | CN103045545B 一种脑炎病毒蛋白及其编码基因和应用 One kind of encephalitis virus protein and its encoding gene and application |
02/11/2015 | CN102675459B Thp蛋白单克隆抗体的制备方法 Preparation Thp monoclonal antibodies |
02/11/2015 | CN102532159B 动点马达蛋白CENP-E小分子抑制剂Syntelin Fixed point motor protein CENP-E small molecule inhibitors Syntelin |
02/11/2015 | CN102427817B 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 Gne protein function due to a reduced treatment of diseases with drugs, food composition, food additives |
02/10/2015 | US8951800 Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation |
02/05/2015 | WO2015016392A1 New causative gene for amyotrophic lateral sclerosis |
02/05/2015 | WO2015016295A1 Pharmaceutical preparation comprising aminopyrazole derivative |
02/05/2015 | WO2015016285A1 Brain function-improving composition |
02/05/2015 | WO2015016206A1 Heterocyclic compound |
02/05/2015 | WO2015016195A1 Wnt SIGNALING INHIBITOR |
02/05/2015 | WO2015016178A1 Function inhibitor of apoptosis-associated speck-like protein containing card comprising 1,5-d-anhydrofructose |
02/05/2015 | WO2015015818A1 Composition for ameliorating metabolic disorders caused by diabetes |
02/05/2015 | WO2015015816A1 Fibroblast activator |
02/05/2015 | WO2015015815A1 Fibroblast activator |
02/05/2015 | WO2015014634A1 Selective at2 receptor agonists for use in treatment of cachexia |
02/05/2015 | US20150038568 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
02/05/2015 | US20150038562 Modified L-nucleic Acid |
02/05/2015 | US20150037309 Preparation for improving the action of receptors |
02/04/2015 | EP2832860A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule |
02/04/2015 | EP2832857A1 Anti-siglec15 antibody with modified cdr |
02/04/2015 | EP2832850A1 Method for producing pluripotent stem cells derived from dental pulp |
02/04/2015 | EP2832734A1 Heterocyclic compound |
02/04/2015 | EP2832733A1 4-alkanoylamino-3-pyrazolone derivative |
02/04/2015 | EP2832732A1 Ppars agonist activity enhancing drug |
02/04/2015 | EP2832728A1 Triazinone compound and t-type calcium channel inhibitor |
02/04/2015 | EP2832726A1 (2-heteroarylamino)succinic acid derivative |
02/04/2015 | EP2832725A1 Aromatic ring compound |